MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Clinical trials for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink returning gynecologic tumors
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib together with radiation therapy for people whose gynecologic cancer (like ovarian, endometrial, or cervical) has returned after previous treatment. The main goal is to find the safest dose and see how well the combination wor…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:48 UTC
-
New drug combo shows promise for Hard-to-Treat HER2+ cancers
Disease control Recruiting nowThis study compares two drugs, neratinib and palbociclib, used together versus neratinib alone for people with HER2-positive gynecologic and other solid tumors (excluding breast cancer). The goal is to see if the combination can shrink or slow cancer growth. About 70 adults with …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
New study tests remote support to ease pain and anxiety after surgery
Symptom relief Recruiting nowThis study compares two different supportive programs delivered remotely to help women recover after surgery for suspected gynecological cancer. The goal is to see which program works better for reducing pain, anxiety, depression, and sleep problems. About 160 women will take par…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 16, 2026 22:44 UTC
-
Home workouts may ease cancer After-Effects
Symptom relief Recruiting nowThis study tests whether a personalized exercise program done at home via Zoom can help gynecologic cancer survivors manage symptoms like pain, fatigue, sleep problems, and brain fog. Researchers will enroll 40 women who have finished cancer treatment. The goal is to see if the p…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Seaweed extract tested as fatigue fighter for cancer patients
Symptom relief Recruiting nowThis study tests whether fucoidan, a supplement from brown seaweed, can prevent or reduce fatigue caused by chemotherapy. About 34 adults with gastrointestinal or gynecologic cancer will take either fucoidan or a placebo daily for 16 weeks. Researchers will track fatigue levels u…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Hormone cream may help Women's vaginal health after cancer radiation
Symptom relief Recruiting nowThis study tests whether a vaginal cream containing the hormone DHEA can improve vaginal health in women who had radiation for gynecologic, anal, or rectal cancer. Radiation often causes dryness, burning, and pain. The trial will enroll 25 women to see if the cream is safe and to…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
Which painkiller works best after gynecologic cancer surgery?
Symptom relief Recruiting nowThis study compares two pain medicines—methadone given through an IV and hydromorphone given near the spine—for women having surgery for gynecologic cancer. The goal is to see which provides better pain relief after surgery. About 140 participants will be enrolled, and their pain…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
Can genetic testing in ethnic populations unlock better cancer screening?
Knowledge-focused Recruiting nowThis study aims to learn more about cancer genes in people from different ethnic backgrounds. Researchers will test 1,800 adults with various solid tumors to see how common certain gene changes are. The goal is to improve cancer risk assessment and tailor screening for these popu…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 16, 2026 22:56 UTC
-
Are surgeons doing enough to prevent blood clots in cancer patients?
Knowledge-focused Recruiting nowThis study surveys surgeons and advanced practice providers to see how often they prescribe extended blood clot prevention after abdominal or pelvic cancer surgery. The goal is to understand current practices and improve guideline use. About 500 participants from the NCORP networ…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 16, 2026 22:43 UTC
-
Can frailty predict cancer recovery? new study aims to find out
Knowledge-focused Recruiting nowThis study follows 500 adults with newly diagnosed gynecologic cancer to understand how frailty—being more vulnerable to stress—affects their recovery and quality of life. Researchers will measure physical frailty using five criteria like weight loss and slow walking. The goal is…
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 16, 2026 22:43 UTC
-
Gene-Guided cancer therapy: a new hope for advanced tumors?
Knowledge-focused Recruiting nowThis study screens patients with advanced solid tumors to find genetic changes in their cancer cells. Based on those results, patients may be matched to a treatment trial that targets their specific tumor mutations. The goal is to improve how doctors choose combination therapies …
Matched conditions: MALIGNANT FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC